Rocatinlimab
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Rocatinlimab, covering 2025-11-03 to 2026-08-28. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]